Company
Jolife
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
2
510(k), De Novo and PMA
Device trials
1
As lead sponsor, any status
Adverse event reports
525
Received Nov 1, 2025 to Nov 20, 2026
Recall records
3
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Jolife, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Jolife.
Latest FDA decisions
K173553 · Decided Feb 8, 2018 · 84 days after receipt
Device type: Compressor, Cardiac, External (DRM) · Cardiology
K161768 · Decided Nov 9, 2016 · 135 days after receipt
Device type: Compressor, Cardiac, External (DRM) · Cardiology
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- A Comparison of Conventional Adult Out-of-hospital Cardiopulmonary Resuscitation Against a Concept With Mechanical Chest Compressions and Simultaneous Defibrillation - LINC StudyPivotal-lookingCompleted
NCT00609778 · 2,500 participants · Start Jan 2008 · Primary completion Aug 2012
Device: LUCAS · For: Cardiovascular Diseases
Sites: Utrecht, Netherlands; Malmö, Sweden; Gävle, Sweden · 6 sites in all
Reports received
525
Received Nov 1, 2025 to Nov 20, 2026. Includes 2 of another or unstated type.
Malfunction reports
500
95% of reports
Injury reports
13
2.5% of reports
Death reports
10
1.9% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 2 | 0 | 0 | 0 |
| Jan 24 | 1 | 0 | 3 | 0 |
| Feb 24 | 2 | 0 | 3 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 1 | 1 | 3 | 0 |
| May 24 | 0 | 6 | 2 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 1 | 0 |
| Sep 24 | 0 | 1 | 0 | 0 |
| Oct 24 | 1 | 0 | 0 | 0 |
| Nov 24 | 0 | 4 | 0 | 0 |
| Dec 24 | 1 | 3 | 1 | 0 |
| Jan 25 | 0 | 1 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 1 | 0 | 0 |
| Apr 25 | 1 | 1 | 0 | 0 |
| May 25 | 0 | 1 | 1 | 0 |
| Jun 25 | 0 | 1 | 0 | 0 |
| Jul 25 | 0 | 2 | 1 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 1 | 0 |
| Oct 25 | 8 | 0 | 0 | 0 |
| Nov 25 | 13 | 0 | 0 | 0 |
| Dec 25 | 42 | 2 | 1 | 0 |
| Jan 26 | 37 | 0 | 0 | 0 |
| Feb 26 | 38 | 2 | 0 | 0 |
| Mar 26 | 34 | 0 | 0 | 0 |
| Apr 26 | 25 | 0 | 0 | 0 |
| May 26 | 31 | 0 | 0 | 0 |
| Jun 26 | 27 | 2 | 1 | 0 |
| Jul 26 | 32 | 5 | 1 | 0 |
| Aug 26 | 171 | 1 | 4 | 2 |
| Sep 26 | 20 | 0 | 3 | 0 |
| Oct 26 | 30 | 1 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2161-2026 · Started Apr 13, 2026 · Posted by FDA May 11, 2026
Reason given: Due to a subset of chest compression systems/devices where the service performed on the systems were not appropriately documented (The documents for the service performed to justify the passing results were not include in the service records).
Cause as FDA categorized it: Under Investigation by firm · Device type: Compressor, Cardiac, External (DRM)
Z-1998-2025 · Started May 21, 2025 · Posted by FDA Jun 20, 2025
Reason given: Due to demonstration units of chest compression system being provided to a customer which may potentially be utilized for clinical use.
Cause as FDA categorized it: Employee error · Device type: Compressor, Cardiac, External (DRM)
Z-1664-2011 · Started Feb 8, 2011 · Posted by FDA Mar 16, 2011
Reason given: LUCAS 2 Chest Compression System may have malfunctions resulting from the failure of a hood probe on the device that connects to the battery. The device may stop in fail safe mode and the LEDs will start flickering or the device will switch off.
Cause as FDA categorized it: Other · Device type: Compressor, Cardiac, External (DRM)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.